National Center for Research Resources; Notice of Meeting, 2866-2867 [05-941]

Download as PDF 2866 Federal Register / Vol. 70, No. 11 / Tuesday, January 18, 2005 / Notices Valley Commerce Bank, both in Phoenix, Arizona. Immediately thereafter, BOKF Merger Corporation Number Eight, Tulsa, Oklahoma, will merge into Valley Commerce Bancorp, Ltd., Phoenix, Arizona. Dated: January 16, 2005. Anna P. Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–881 Filed 1–14–05; 8:45 am] Board of Governors of the Federal Reserve System, January 11, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–873 Filed 1–14–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–S BILLING CODE 4010–01–M National Institutes of Health National Cancer Institute; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health; National Cancer Institute Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel Experimental Therapeutics 1. Date: January 31, 2005. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Seattle Downtown/Lake Union, 925 Westlake Avenue North, Seattle, WA 98109. Contact Person: William D. Merritt, PhD, Scientific Review Administrator, Grants Review Branch, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8034, MSC 8328, Bethesda, MD 20881–8238, 301–496–9767. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction, 93.393, Cancer Cause and Prevention Research, 93,394, Cancer Detection and Diagnosis Research, 93.395, Cancer Treatment Research, 93.396, Cancer Biology Research, 93.397, Cancer Centers Support, 93.398, Cancer Research Manpower, 93.399, Cancer Control, National Institutes of Health, HHS) VerDate jul<14>2003 11:51 Jan 14, 2005 Jkt 205001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel Targeted Therapy II. Date: February 15, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave, Bethesda, MD 20814. Contact Person: Virginia P. Wray, PhD, Deputy Chief, Research Program Review Branch, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8125, Bethesda, MD 20892–8328, 301–496– 9236, vw8z@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 10, 2005. Anna P. Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–882 Filed 1–14–05; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6, title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Antibody Array for Cancer Detection. Date: March 3, 2005. Time: 1 p.m. to 3:30 p.m. Agenda: To review and evaluate contract proposals. Place: EPN, 6130 Executive Blvd., Rockville, MD 20852 (Telephone Conference Call). Contact Person: Timothy C. Meeker, MD, Scientific Review Administrator, Special Referral and Resources Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8088, Rockville, MD 20852; (301) 594–1279. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 11, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–946 Filed 1–14–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby give of the following meeting. E:\FR\FM\18JAN1.SGM 18JAN1 Federal Register / Vol. 70, No. 11 / Tuesday, January 18, 2005 / Notices The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant application, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Initial Review Group, Clinical Research Review Committee, RIRG– G. Date: February 9–10, 2005. Open: February 9, 2005 8 a.m. to 9 a.m. Agenda: To discuss program planning and other issues. Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20852. Closed: February 9, 2005, 9 a.m. to adjournment. Agenda: To review and evaluate grant applications. Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Mohan Viswanathan, PhD, Deputy Director, National Center for Research Resources, OR, National Institutes of Health, 6701 Democracy Blvd., Room 1084, MSC 4874, 1 Democracy Plaza, Bethesda, MD 20892–4874, 301–435–0829, mv10f@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS) Dated: January 11, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–941 Filed 1–14–05; 8:45 am] The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel; Functional BIRN. Date: January 28, 2005. Time: 8 a.m. to adjournment. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Linda C. Duffy, PhD, Scientific Review Administrator, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd, Room 1082, Bethesda, MD 20892, (301) 435–0810, duffyl@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Center for Research Resources Special Emphasis Panel. Date: February 10–11, 2005. Time: February 10, 2005, 8 a.m. to adjournment. Agenda: To review and evaluate grant applications. Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Linda C. Duffy, PhD, Scientific Review Administrator, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd, Room 1082, Bethesda, MD 20892, (301) 435–0810, duffyl@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333 National Institutes of Health, HHS.) Dated: January 11, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–942 Filed 1–14–05; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center for Research Resources; Notice of Closed Meetings National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. VerDate jul<14>2003 11:51 Jan 14, 2005 Jkt 205001 National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 2867 is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review of Program Project Applications (P01s). Date: February 23, 2005. Time: 1:30 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Judy S. Hannah, PhD, Scientific Review Administrator, Review Branch, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892, 301/ 435–0287. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review Research Program Project (P01) Applications. Date: March 1, 2005. Time: 9 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: The Watergate Hotel, 2650 Virginia Ave, NW., Washington, DC 20037. Contact Person: Irina Gordienko, Scientific Review Administrator, Division of Extramural Activities, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7180, MSC 7924, Bethesda, MD 20892, 301/435– 0270. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Thalassemia Research Network. Date: March 2, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Inner Harbor Hotel, 300 South Charles Street, Baltimore, MD 21201. Contact Person: Patricia A. Haggerty, PhD, Scientific Review Administrator, National Heart, Lung, and Blood Institute/NIH, Clinical Studies & Training Studies Rev. Grp., Division of Extramural Affairs/Section Chief, 6701 Rockledge Drive, Room 7194, Bethesda, MD 20892, 301/435–0288. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review of Research Projects (U01) Cooperative Agreements. Date: March 17–18, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\18JAN1.SGM 18JAN1

Agencies

[Federal Register Volume 70, Number 11 (Tuesday, January 18, 2005)]
[Notices]
[Pages 2866-2867]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-941]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Research Resources; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby give of the following 
meeting.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.

[[Page 2867]]

    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant application, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Research Resources 
Initial Review Group, Clinical Research Review Committee, RIRG-G.
    Date: February 9-10, 2005.
    Open: February 9, 2005 8 a.m. to 9 a.m.
    Agenda: To discuss program planning and other issues.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Closed: February 9, 2005, 9 a.m. to adjournment.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Mohan Viswanathan, PhD, Deputy Director, 
National Center for Research Resources, OR, National Institutes of 
Health, 6701 Democracy Blvd., Room 1084, MSC 4874, 1 Democracy 
Plaza, Bethesda, MD 20892-4874, 301-435-0829, mv10f@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical 
Technology; 93.389, Research Infrastructure, 93.306, 93.333, 
National Institutes of Health, HHS)

    Dated: January 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-941 Filed 1-14-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.